Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.

Antineoplastic and immunomodulating drugs

CPI-0610

Другие языки:

CPI-0610

Подписчиков: 0, рейтинг: 0

CPI-0610
Identifiers

IUPAC name 2-[(4S)-6-(4-chlorophenyl)-1-methyl-4H-[1,2]oxazolo[5,4-d][2]benzazepin-4-yl]acetamide
CAS Number	1380087-89-7
PubChem CID	57389999
ChemSpider	32738784
UNII	U4017GUQ06
ChEBI	CHEBI:189653
Chemical and physical data
Formula	C₂₀H₁₆ClN₃O₂
Molar mass	365.82 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CC1=NOC2=C1C3=CC=CC=C3C(=N[C@H]2CC(=O)N)C4=CC=C(C=C4)Cl
InChI InChI=1S/C20H16ClN3O2/c1-11-18-14-4-2-3-5-15(14)19(12-6-8-13(21)9-7-12)23-16(10-17(22)25)20(18)26-24-11/h2-9,16H,10H2,1H3,(H2,22,25)/t16-/m0/s1 Key:GCWIQUVXWZWCLE-INIZCTEOSA-N

CPI-0610 is a drug which acts as a BET inhibitor, mainly acting at the BRD2 and BRD4 subtypes. It has potential applications in the treatment of various forms of cancer.